GOVXW - GeoVax Labs Inc. (GOVX) Q1 2024 Earnings Call Transcript
2024-05-14 20:01:02 ET
GeoVax Labs, Inc. (GOVX)
Q1 2024 Earnings Conference Call
May 14, 2024, 04:30 PM ET
Company Participants
Max Gadicke - Investor Relations, Stern IR
David Dodd - Chairman & Chief Executive Officer
Mark Reynolds - Chief Financial Officer
Kelly McKee - Chief Medical Officer
John Sharkey - Vice President, Business Development
Conference Call Participants
Robert LeBoyer - Noble Capital Markets
Presentation
Operator
Good afternoon, and welcome everyone to the GeoVax First Quarter 2024 Corporate Update Call. My name is Mark, and I will facilitate today's call.
With me are David Dodd, Chairman and CEO; Mark Reynolds, Chief Financial Officer; Mark Newman, PhD, Chief Scientific Officer; Kelly McKee, MD, MPH, Chief Medical Officer; and John Sharkey, PhD, Vice President, Business Development.
At this time, all participants are in a listen-only mode, and a question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded....
GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript